A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Harmony Biosciences Management, Inc.
- Study ID
- NCT07500090
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Idiopathic Hypersomnia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- HBS-301 tablet — DRUGHBS-301 tablet
- Placebo — DRUGPlacebo tablet
Study Details
This is a Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled clinical study to assess the efficacy and safety of HBS-301 in adult participants (ages ≥18 years) with idiopathic hypersomnia (IH).
Key Dates
- First listed
- Mar 30, 2026
- Start date
- Mar 16, 2026
- Status verified
- Jun 2026
- Primary completion
- Oct 31, 2027
- Completion
- Oct 31, 2028
Study Design
- Enrollment
- 248 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Double-Blind Treatment Period HBS-301HBS-301 tablets administered once daily in the morning upon wakening
- Placebo Comparator: Double-blind Treatment Period PlaceboMatching placebo tablets administered once daily in the morning upon wakening
- Experimental: Open-label Extension Period HBS-301HBS-301 tablets administered once daily in the morning upon wakening
Primary Outcome Measure
Change in severity of EDS as measured by the Epworth Sleepiness Scale (ESS) [ Time Frame: Baseline to the end of the Double-blind Treatment Period (8 weeks) ]
Central Contacts
- Katie Wilmsen443-309-5556
- Michelle Manuel847-903-4610
Locations (22)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sleep Disorders Center of Alabama | Birmingham | Alabama | 35213 | |
| Stanford Center for Sleep Medicine | Redwood City | California | 94063 | Oliver Sum-Ping, MD (PRINCIPAL_INVESTIGATOR) |
| Santa Monica Clinical Trials | Santa Monica | California | 90404 | Jualynda Smith Daniel Norman, MD (PRINCIPAL_INVESTIGATOR) |
| Alpine Clinical Research Center, Inc. | Boulder | Colorado | 80301 | |
| PharmDev Research Institute, LLC | Miami | Florida | 33176 | Lisbet Machado Cordova, APRN Edward Mezerhane, MD (PRINCIPAL_INVESTIGATOR) |
| Central Florida Pediatric Sleep Disorders Institute (Florida Pediatric Research Institute, LLC) | Winter Park | Florida | 32789 | Akinyemi Ajayi, MD |
| NeuroTrials Research Inc. | Atlanta | Georgia | 30328 | Dennis Lacey, MD Melody Dennis Lacey, MD (PRINCIPAL_INVESTIGATOR) |
| Sleep Practitioners, LLC | Macon | Georgia | 31210 | |
| Phillip Nowlin | Stockbridge | Georgia | 30281 | Phillip Nowlin, MD |
| Revive Research Institute | Southfield | Michigan | 48975 | Syed Muhammad Talib Rizvi Raza, MD (PRINCIPAL_INVESTIGATOR) |
| St. Luke's Hospital, Sleep Medicine and Research Center | Chesterfield | Missouri | 63017 | Michael McLeland, PhD Michael McLeland, PhD (PRINCIPAL_INVESTIGATOR) |
| Clinical Research of Gastonia | Gastonia | North Carolina | 28054 | Anup Banerjee, MD (PRINCIPAL_INVESTIGATOR) |
| Stern Research Partners, LLC | Huntersville | North Carolina | 28078 | Thomas Stern, MD (PRINCIPAL_INVESTIGATOR) |
| David Kudrow, MD | Morrisville | North Carolina | 27560 | David Kudrow, MD |
| Suburban Research Associates | West Chester | Pennsylvania | 19380 | Omer Abdullah, MD (PRINCIPAL_INVESTIGATOR) |
| Respiratory Specialists | Wyomissing | Pennsylvania | 19610 | Alex Platt, MD Alec Platt, MD (PRINCIPAL_INVESTIGATOR) |
| Lowcountry Lung and Critical Care, PA | Charleston | South Carolina | 29406 | |
| Bogan Sleep Consultants, LLC | Columbia | South Carolina | 29201 | |
| K2 Medical Research | Nashville | Tennessee | 37204 | Auchaia Farley, PA Joshua Lennon, MD (PRINCIPAL_INVESTIGATOR) |
| Southwest Family Medicine Associates | Dallas | Texas | 75235 | |
| HAS Research | San Antonio | Texas | 78240 | Hernan A Salazar, DO (PRINCIPAL_INVESTIGATOR) |
| West Virginia University | Morgantown | West Virginia | 26506 |
Find similar trials in Birmingham, AL
By research site
Sleep Disorders Center of Alabama· Birmingham, ALStanford Center for Sleep Medicine· Redwood City, CASanta Monica Clinical Trials· Santa Monica, CAAlpine Clinical Research Center, Inc.· Boulder, COPharmDev Research Institute, LLC· Miami, FLCentral Florida Pediatric Sleep Disorders Institute (Florida Pediatric Research Institute, LLC)· Winter Park, FL
Related Studies
- Low Sodium Oxybate in Patients With Idiopathic HypersomniaPHASE4 · Recruiting · Mayo Clinic · Phoenix, Arizona
- Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic InsomniaPHASE1 · Not Yet Recruiting · Nyree Penn · Aventura, Florida
- A Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaPHASE2 · Recruiting · Centessa Pharmaceuticals (UK) Limited · Auburn, Alabama
- A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic HypersomniaPHASE2/PHASE3 · Recruiting · Alkermes, Inc. · Phoenix, Arizona